CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
12.57
+0.49 (4.06%)
Aug 14, 2025, 2:33 PM - Market open
CorMedix Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 159.31 | 40.65 | 43.64 | 43.15 | 53.32 | 41.91 | Upgrade
|
| Short-Term Investments | 31.4 | 11.04 | 32.39 | 15.64 | 12.15 | 4.44 | Upgrade
|
| Cash & Short-Term Investments | 190.71 | 51.69 | 76.03 | 58.79 | 65.47 | 46.35 | Upgrade
|
| Cash Growth | 318.13% | -32.02% | 29.32% | -10.20% | 41.24% | 63.58% | Upgrade
|
| Receivables | 42.91 | 51.65 | - | - | 0.05 | 0 | Upgrade
|
| Inventory | 9.63 | 7.6 | 2.11 | - | 0 | 0.14 | Upgrade
|
| Prepaid Expenses | 4.61 | 3.39 | 0.76 | 0.62 | 0.77 | 1.41 | Upgrade
|
| Restricted Cash | - | - | 0.08 | 0.12 | 0.13 | 0.19 | Upgrade
|
| Other Current Assets | 0.18 | 0.24 | 0.47 | 0.01 | 0.05 | 0.08 | Upgrade
|
| Total Current Assets | 248.06 | 114.58 | 79.45 | 59.55 | 66.47 | 48.18 | Upgrade
|
| Property, Plant & Equipment | 2.05 | 2.32 | 2.51 | 2.38 | 2.37 | 1.13 | Upgrade
|
| Other Intangible Assets | 1.74 | 1.84 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.75 | 0.11 | 0.1 | 0.1 | 0.1 | - | Upgrade
|
| Total Assets | 252.6 | 118.85 | 82.06 | 62.04 | 68.95 | 49.31 | Upgrade
|
| Accounts Payable | 5.82 | 1.72 | 4.28 | 2.2 | 2.21 | 1.13 | Upgrade
|
| Accrued Expenses | 25.2 | 29.95 | 6.97 | 3.97 | 3.01 | 2.92 | Upgrade
|
| Current Portion of Leases | 0.18 | 0.17 | 0.15 | 0.13 | 0.12 | 0.11 | Upgrade
|
| Current Income Taxes Payable | 0.52 | - | - | - | - | - | Upgrade
|
| Other Current Liabilities | - | 2 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 31.71 | 33.84 | 11.4 | 6.31 | 5.35 | 4.16 | Upgrade
|
| Long-Term Leases | 0.26 | 0.35 | 0.52 | 0.67 | 0.8 | 0.92 | Upgrade
|
| Total Liabilities | 31.97 | 34.19 | 11.92 | 6.98 | 6.15 | 5.09 | Upgrade
|
| Common Stock | 0.07 | 0.06 | 0.05 | 0.04 | 0.04 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 519.63 | 424.13 | 391.69 | 330.29 | 308.33 | 261.54 | Upgrade
|
| Retained Earnings | -299.16 | -339.63 | -321.7 | -275.36 | -245.66 | -217.45 | Upgrade
|
| Comprehensive Income & Other | 0.08 | 0.09 | 0.09 | 0.08 | 0.09 | 0.1 | Upgrade
|
| Total Common Equity | 220.63 | 84.66 | 70.14 | 55.06 | 62.8 | 44.22 | Upgrade
|
| Shareholders' Equity | 220.63 | 84.66 | 70.14 | 55.06 | 62.8 | 44.22 | Upgrade
|
| Total Liabilities & Equity | 252.6 | 118.85 | 82.06 | 62.04 | 68.95 | 49.31 | Upgrade
|
| Total Debt | 0.44 | 0.52 | 0.67 | 0.8 | 0.92 | 1.03 | Upgrade
|
| Net Cash (Debt) | 190.28 | 51.17 | 75.36 | 57.99 | 64.54 | 45.32 | Upgrade
|
| Net Cash Growth | 322.69% | -32.10% | 29.96% | -10.15% | 42.43% | 59.96% | Upgrade
|
| Net Cash Per Share | 2.92 | 0.87 | 1.48 | 1.44 | 1.71 | 1.59 | Upgrade
|
| Filing Date Shares Outstanding | 74.65 | 65.18 | 54.98 | 44.48 | 38.71 | 38 | Upgrade
|
| Total Common Shares Outstanding | 74.62 | 64.41 | 54.94 | 42.79 | 38.06 | 33.54 | Upgrade
|
| Working Capital | 216.35 | 80.74 | 68.05 | 53.24 | 61.12 | 44.02 | Upgrade
|
| Book Value Per Share | 2.96 | 1.31 | 1.28 | 1.29 | 1.65 | 1.32 | Upgrade
|
| Tangible Book Value | 218.89 | 82.81 | 70.14 | 55.06 | 62.8 | 44.22 | Upgrade
|
| Tangible Book Value Per Share | 2.93 | 1.29 | 1.28 | 1.29 | 1.65 | 1.32 | Upgrade
|
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.